Stocks · Healthcare · Medical - Devices
Beta Bionics, Inc. BBNX
$18.96 +0.48% Close, Oct 2, 2026 · NASDAQ · Market cap $853.0M
Strong growth
Next earnings report: Oct 27, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -69.8% from -80.1% a year earlier.
- Revenue over the last four quarters was $119.0M, up 52.5% from a year earlier, slowing from 57.9% a quarter earlier.
- Earnings beat analyst estimates in each of the last 5 quarters (average surprise over the last four: +17.9%).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 16%
- Revenue growth, 3-year CAGRTop 1%
- Revenue growth accelerationBottom 25%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 41%
- Gross marginBottom 44%
- Operating marginBottom 33%
- Accruals (lower is better)Bottom 46%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 48%
- Free-cash-flow yieldBottom 44%
- EBITDA / enterprise valueBottom 41%
- Sales / enterprise valueBottom 39%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 33%
- 6-month returnTop 10%
- 1-year return vs S&P 500Bottom 39%
- Distance from 52-week highBottom 39%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 26%
- Consecutive EPS beatsTop 15%
- Share of analysts rating BuyBottom 47%
- Upside to consensus price targetBottom 27%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 20%
- Maximum drawdown, 3 yearsBottom 47%
- Beta vs S&P 500 (lower is better)Bottom 43%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 57.9% | 52.5% | ↓ |
| Gross margin | 53.9% | 58.3% | ↑ |
| Operating margin | -80.1% | -69.8% | ↑ |
| FCF margin | -79.5% | -51.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 52.5% | 57.9% | ↓ | Top 16% |
| Gross margin | 58.3% | 53.9% | ↑ | Bottom 44% |
| Operating margin | -69.8% | -80.1% | ↑ | Bottom 33% |
| Net margin | -61.3% | -94.0% | ↑ | — |
| Free-cash-flow margin | -51.6% | -79.5% | ↑ | — |
| Return on invested capital | -31.0% | — | Bottom 41% | |
| Revenue growth, 3-year CAGR | 724.3% | — | Top 1% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 17.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -3.9 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.72%
- Shareholder yield
- -0.72%
- Share count change, 1 year
- +2.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 29, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 5
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +17.9%
- Average 2-day reaction, last 8
- +0.3%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $23.00
- Target vs current price
- +21.3%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 75%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | +8.8% | -4.0% | -7.8% | +22.4% | — |
| Apr 21, 2026 | +7.5% | -5.0% | -17.5% | -27.2% | +30.9% |
| Feb 17, 2026 | +28.6% | +0.2% | -1.3% | -22.0% | -29.6% |
| Oct 28, 2025 | +26.7% | +2.2% | +16.7% | +32.2% | -32.8% |
| Jul 29, 2025 | +23.5% | +4.8% | +17.4% | +24.7% | +50.0% |
| May 6, 2025 | -2.0% | -2.8% | +21.4% | +53.8% | +43.8% |
| Mar 25, 2025 | -333.3% | +2.5% | -17.6% | -30.0% | +19.7% |
| Feb 26, 2025 | +50.7% | +4.3% | -3.7% | -20.6% | -18.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | -$0.53 | -$0.58 | +8.8% | $32.0M |
| Apr 21, 2026 | -$0.49 | -$0.53 | +7.5% | $27.6M |
| Feb 17, 2026 | -$0.30 | -$0.42 | +28.6% | $32.1M |
| Oct 28, 2025 | -$0.33 | -$0.45 | +26.7% | $27.3M |
| Jul 29, 2025 | -$0.39 | -$0.51 | +23.5% | $23.2M |
| May 6, 2025 | -$0.52 | -$0.51 | -2.0% | $17.6M |
| Mar 25, 2025 | -$1.82 | -$0.42 | -333.3% | $20.4M |
| Feb 26, 2025 | -$0.60 | -$1.22 | +50.7% | $20.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 6.85× | — | — | Bottom 39% |
| Free-cash-flow yield | -7.20% | — | — | Bottom 44% |
| Earnings yield | -8.86% | — | — | Bottom 48% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 14
- Days above the 200-day average
- 16
- 50-day average slope (20 days)
- +7.4%
- 200-day average slope (20 days)
- -5.7%
- Distance from 50-day average
- +3.3%
- Distance from 200-day average
- +19.9%
- RSI (14)
- 45.9
- Relative volume
- 0.32×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 77.2%
- Volatility vs own 5-year history
- 52th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.25
- Correlation with S&P 500
- 0.20
- Current drawdown from 1-year high
- -40.7%
- Maximum drawdown, 3 years
- -72.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 8, 2026 | Apr 10, 2026 | -72.3% | 63 days | Not yet recovered |
| Jan 31, 2025 | Apr 8, 2025 | -59.2% | 46 days | 105 days (Sep 9, 2025) |
| Sep 12, 2025 | Sep 26, 2025 | -26.1% | 10 days | 23 days (Oct 29, 2025) |
| Nov 25, 2025 | Dec 8, 2025 | -10.2% | 8 days | 10 days (Dec 22, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $853.0M
- EPS, diluted (TTM)
- -$1.68
- Revenue (TTM)
- $119.0M
- 52-week range
- $8.80 – $32.71
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $179,000 | $12.0M | $65.1M | $100.3M |
| Gross profit | $179,000 | $6.3M | $35.9M | $55.5M |
| Operating income | -$65.8M | -$35.9M | -$45.3M | -$71.7M |
| Net income | -$64.8M | -$44.1M | -$54.8M | -$73.2M |
| EPS (diluted) | -$1.51 | -$1.03 | -$1.28 | -$1.81 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.7M | $20.4M | $17.6M | $23.2M | $27.3M | $32.1M | $27.6M | $32.0M |
| Net income | -$9.7M | -$18.1M | -$28.7M | -$16.9M | -$14.2M | -$13.5M | -$21.9M | -$23.4M |
| EPS (diluted) | -$0.23 | -$0.42 | -$0.66 | -$0.39 | -$0.33 | -$0.33 | -$0.49 | -$0.53 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Operating cash flow | -$60.2M | -$32.4M | -$48.3M | -$50.9M |
| Capital expenditure | -$772,000 | -$402,000 | -$3.4M | -$5.3M |
| Free cash flow | -$61.0M | -$32.8M | -$51.7M | -$56.2M |
| Dividends paid | $0 | $0 | $0 | $0 |
| Net share buybacks | $389,000 | $29,000 | $102,000 | $214.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $180.5M
- Total assets
- $292.4M
- Total liabilities
- $36.0M
- Total debt
- $6.5M
- Net debt
- -$37.8M
- Shareholders’ equity
- $256.4M
As of Jun 30, 2026 (filed Jul 29, 2026).
Short interest
- Shares sold short
- 10,617,768
- Days to cover
- 9.91
- Change vs previous report
- +13.0%
FINRA short interest, settlement date Sep 15, 2026.